Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: Provided is a valve mechanism which has a simple configuration, being available for a type having a large bore diameter, and being able to be opened in response to extremely high temperature to supply fire-fighting water or cooling water. There is provided a valve mechanism opened in response to extremely high temperature, the valve mechanism including: a cylindrical body that is attached to an end of a supply pipe connected to a water source; a stopper that blocks a channel inside the body; a support that is disposed inside the body and that supports the stopper by pressing the stopper to a side of the supply pipe; a locking unit that serves to lock the support in a normal state and that unlocks the support in the case of extremely high temperature; and a heat sensitive section that releases the locking unit in the case where temperature of environment is increased to an extremely high level.

Abstract: The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: A fuel cell control system is provided which is designed to ensure the stability of operation of a fuel cell stack. The system includes a magnetic sensor and a controller. The magnetic sensor works to measure a change in magnetic flux density of magnetic field produced by an electric current as generated by electrochemical reaction taken place in each of fuel cells. The controller is designed to analyze the change in magnetic flux density measured by the magnetic sensor to specify the cause and location resulting in a drop in ability of the fuel cell stack to generate electricity which is to occur partially in the fuel cell stack. The controller takes a predetermined measure to control the operation of the fuel cell stack for eliminating the drop in ability of the fuel cell stack to generate the electricity.

Abstract: A secondary battery charging system, mounted on a vehicle having an internal combustion engine, has a secondary battery, a fuel cell, a fuel storage unit, and a fuel supply controller. In order to start the engine of the vehicle, the engine requires the electric power from the secondary battery. The fuel storage unit stores a fuel to be supplied to the fuel cell. When a given condition is satisfied, the fuel supply controller instructs the fuel storage unit to supply the fuel to the fuel cell in order to start the operation of the engine of the vehicle. The fuel cell thereby starts the generation of the electric power by performing electric chemical reaction and supplies the generated electric power to the secondary battery. The secondary battery supplies the electric power to the engine of the vehicle. The engine initiates its operation.

Abstract: An electric power generation system is mounted on a vehicle having a secondary battery, an electric load, and an internal combustion engine as a driving source consuming gasoline in a mixed fuel which mainly consists of the gasoline and ethanol. The electric power generation system has a fuel cell for generating electric power by electric chemical reaction and a fuel storage unit having an ethanol selection permeable membrane for separating the ethanol from the mixed fuel involving the ethanol and gasoline. On satisfying a given condition, the fuel cell receives the ethanol from the permeable membrane and initiates the generation of electric power, and supplies the generated electric power to at least one of the secondary battery and the electric load.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: Problems: A conventional alloy for a fusible plug contained harmful elements such as Cd and Pb, and there was a concern of pollution by these harmful elements. The present invention provides a fusible plug which does not contain the harmful elements Cd and Pb, with which the alloy is not forced out of the fusible plug even when used for long periods as a safety device for refrigeration equipment, and which has a strong mechanical strength such as creep strength. Means for Solving the Problem: A fusible plug employs an alloy for fusible plugs which comprises 5-8 mass % of Sn, 31-34 mass % of Bi, 0.2-4 mass % of Sb, and a remainder of In and which melts at approximately 66-70° C. A total of at most 2.0 mass % of at least one element selected from strengthening elements consisting of 0.1-1.0 mass % of Cu, 0.1-1.0 mass % of Ge, 0.1-0.7 mass % of Ag, 0.1-0.6 mass % of Au, 0.2-0.6 mass % of Zn, 0.02-0.1 mass % of Ni, and 0.01-0.1 mass % of a lanthanoid may be added.

Abstract: The present invention is directed to overcome such a problem associated with a sprinkler head made of In-based alloy with no use of Pb or Cd that in contradiction with the fact that a testing temperature in a strength test of a sprinkler head is proximal to a melting temperature of a solder alloy used in a heat-sensitive decomposition structure of the sprinkler head, and therefore a good creeping property over a higher temperature zone in which a sprinkler is activated is required, typically, the sprinkler head made of the In-based alloy with no use of Pb or Cd could not achieve the creeping property over the higher temperature zone in which the sprinkler is activated as favorably as any conventional sprinkler head using Pb or Cd could do, and could occasionally end in failure in a durability test. To solve the above problem, the present invention provides an alloy usable for a heat-sensitive material in a sprinkler head, which is composed of Sn in an amount of 0.1-2.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.

Abstract: Problem A conventional alloy for a fusible plug contained harmful elements such as Cd or Pb, so there was a concern of pollution by these harmful elements. The present invention provides a fusible plug which does not contain the harmful components Cd or Pb, with which the alloy is not forced out of the fusible plug even when used for long periods as a safety device for refrigeration equipment, and which has a high mechanical strength such as creep strength. Means for Solving the Problem A fusible plug is used which employs a fusible alloy consisting essentially of 0.1-2.0 mass percent of Sn, 31-37 mass percent of Bi, and a remainder of In, the alloy melting at approximately at 70-75° C. A fusible plug is used which employs an alloy consisting essentially of 0.05-0.4 mass percent of Zn, 47-55 mass percent of Bi, and a remainder of In, the alloy melting at approximately 90-95° C.

Abstract: The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-sero-tonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamaza-pine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.

Abstract: A fuel cell stack has plural fuel cells stacked in series along a direction vertical to a main surface of each fuel cell. Each fuel cell has a lamination body made of an anode, a cathode, and a polymer proton exchange membrane. The lamination body is sandwiched between a pair of separators. Each of the anode and cathode has a catalyst layer and a diffusion layer laminated. A water collecting groove and fuel gas passages are formed in the inner surface of each separator. The bottom end of the water collection groove is lower in position than the end of the catalyst layer and the diffusion layer. The water collecting groove is not joined to the fuel gas passages and collects water produced by electrochemical reaction in each fuel cell, and drains the collected water.

Abstract: An electric power generation system is mounted on a vehicle having a secondary battery, an electric load, and an internal combustion engine as a driving source consuming gasoline in a mixed fuel which mainly consists of the gasoline and ethanol. The electric power generation system has a fuel cell for generating electric power by electric chemical reaction and a fuel storage unit having an ethanol selection permeable membrane for separating the ethanol from the mixed fuel involving the ethanol and gasoline. On satisfying a given condition, the fuel cell receives the ethanol from the permeable membrane and initiates the generation of electric power, and supplies the generated electric power at least one of the secondary battery and the electric load.

Abstract: A secondary battery charging system, mounted on a vehicle having an internal combustion engine, has a secondary battery, a fuel cell, a fuel storage unit, and a fuel supply controller. In order to start the engine of the vehicle, the engine requires the electric power from the secondary battery. The fuel storage unit stores a fuel to be supplied to the fuel cell. When a given condition is satisfied, the fuel supply controller instructs the fuel storage unit to supply the fuel to the fuel cell in order to start the operation of the engine of the vehicle. The fuel cell thereby starts the generation of the electric power by performing electric chemical reaction and supplies the generated electric power to the secondary battery. The secondary battery supplies the electric power to the engine of the vehicle. The engine initiates its operation.

Abstract: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.